This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Hemispherx Biopharma Inc.
HEB : AMEX : Health Care

$0.33 0.02 | 5.93%
Today's Range: 0.31 - 0.33
Avg. Daily Volume: 2,596,600
04/16/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
HEB HEMISPHERX BIOPHARMA INC 0.41 70.82 n/m 0.17 -15.66
AVEO AVEO PHARMACEUTICALS INC 1.81 93.87 n/m 16.50 240.15
OXBT OXYGEN BIOTHERAPEUTICS INC 6.25 85.44 n/m 0.68 -35.05
STEM STEMCELLS INC 1.40 77.19 n/m 1.20 -12.07
CYCC CYCLACEL PHARMACEUTICALS 3.90 75.78 n/m 0.79 1134.37
CVM CEL-SCI CORP 1.27 71.04 n/m 0.26 -2.65
APPY VENAXIS INC 3.29 70.58 n/m 0.14 37.37
CLSN CELSION CORP 3.83 65.93 n/m 0.38 n/a
RXII RXI PHARMACEUTICALS CORP 5.50 64.26 n/m 0.41 619.29
LPTN LPATH INC 4.83 63.67 n/m 6.87 -21.91
TTNP TITAN PHARMACEUTICALS INC 0.73 60.26 10.43 12.83 143.38
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

HEB Ind Avg S&P 500
n/m 52.21 19.56

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs